| 发明名称 |
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer |
| 摘要 |
The present invention discloses methods of using the methylation status of the COX-2 gene promoter region as a biomarker for a gastric cancer patient to determine a prognosis and a treatment regimen, and to monitor the progress of a treatment regimen. |
| 申请公布号 |
US8288099(B2) |
申请公布日期 |
2012.10.16 |
| 申请号 |
US20090637610 |
申请日期 |
2009.12.14 |
| 申请人 |
HOON DAVE S. B.;DE MAAT MICHIEL;JOHN WAYNE CANCER INSTITUTE |
发明人 |
HOON DAVE S. B.;DE MAAT MICHIEL |
| 分类号 |
C12Q1/68;C07H21/02;C07H21/04 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
